HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Otto S Hoekstra Selected Research

Inflammation (Inflammations)

6/2022Dual time point imaging in locally advanced head and neck cancer to assess residual nodal disease after chemoradiotherapy.
1/2019F8-IL10: A New Potential Antirheumatic Drug Evaluated by a PET-Guided Translational Approach.
11/2014Detection of subclinical synovitis with macrophage targeting and positron emission tomography in patients with rheumatoid arthritis without clinical arthritis.
4/2012Bone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Otto S Hoekstra Research Topics

Disease

69Neoplasms (Cancer)
01/2023 - 01/2002
26Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 01/2002
23Neoplasm Metastasis (Metastasis)
01/2021 - 01/2002
18Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2012
12Carcinoma (Carcinomatosis)
01/2019 - 09/2004
11Head and Neck Neoplasms (Head and Neck Cancer)
06/2022 - 09/2004
10Breast Neoplasms (Breast Cancer)
10/2021 - 01/2002
10Squamous Cell Carcinoma of Head and Neck
09/2020 - 04/2011
10Glioma (Gliomas)
01/2020 - 10/2003
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 01/2014
8Lymphatic Metastasis
01/2020 - 10/2004
6Rheumatoid Arthritis
01/2020 - 01/2011
6Colorectal Neoplasms (Colorectal Cancer)
11/2017 - 02/2014
5Lymphoma (Lymphomas)
10/2020 - 04/2006
5Hypoxia (Hypoxemia)
01/2017 - 01/2002
4Inflammation (Inflammations)
06/2022 - 04/2012
4Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2022 - 11/2003
3Glioblastoma (Glioblastoma Multiforme)
01/2020 - 06/2012
3Arthritis (Polyarthritis)
01/2020 - 01/2012
3Melanoma (Melanoma, Malignant)
11/2019 - 07/2006
3Body Weight (Weight, Body)
01/2019 - 11/2009
3Diffuse Intrinsic Pontine Glioma
01/2018 - 01/2014
3Pain (Aches)
08/2017 - 11/2004
3Thyroid Neoplasms (Thyroid Cancer)
05/2016 - 06/2014
3Synovitis
09/2015 - 01/2012
3Esophageal Neoplasms (Esophageal Cancer)
01/2011 - 09/2005
2Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 08/2019
2Lung Neoplasms (Lung Cancer)
02/2022 - 05/2011
2Hodgkin Disease (Hodgkin's Disease)
01/2022 - 04/2006
2Disease Progression
01/2021 - 01/2017
2Laryngeal Neoplasms (Laryngeal Cancer)
01/2019 - 02/2013
2Brain Neoplasms (Brain Tumor)
05/2017 - 01/2014
2Mouth Neoplasms (Oral Cancer)
02/2017 - 04/2013
2Margins of Excision
02/2016 - 11/2007
2Adenocarcinoma
01/2016 - 02/2008
2Coronary Artery Disease (Coronary Atherosclerosis)
04/2012 - 04/2012
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2011 - 05/2011
2Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2008 - 09/2007

Drug/Important Bio-Agent (IBA)

42Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2023 - 04/2002
16Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2006
14Glucose (Dextrose)FDA LinkGeneric
10/2016 - 01/2002
8AntigensIBA
01/2021 - 01/2016
5Monoclonal AntibodiesIBA
03/2022 - 10/2015
5fluoromethylcholineIBA
10/2017 - 01/2012
4Androgen Receptors (Androgen Receptor)IBA
07/2019 - 12/2017
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 01/2002
4Bevacizumab (Avastin)FDA Link
01/2018 - 01/2011
4Deoxyglucose (2 Deoxy D glucose)IBA
08/2014 - 12/2011
3Rituximab (Mabthera)FDA Link
10/2020 - 01/2016
3Tyrosine (L-Tyrosine)FDA Link
01/2020 - 07/2018
3Choline (Choline Chloride)IBA
06/2019 - 05/2016
3ErbB Receptors (EGF Receptor)IBA
01/2019 - 10/2015
3AlbuminsIBA
02/2018 - 10/2011
3Docetaxel (Taxotere)FDA Link
08/2017 - 02/2013
3alovudineIBA
08/2017 - 12/2010
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2017 - 01/2011
3Fluorine-18IBA
08/2014 - 08/2002
3Thallium-201IBA
06/2012 - 10/2003
2G250 monoclonal antibodyIBA
01/2023 - 08/2019
2B7-H1 AntigenIBA
03/2022 - 01/2022
289Zr-rituximabIBA
02/2022 - 01/2017
2Estrogen ReceptorsIBA
10/2021 - 12/2017
2Polyvinyl Chloride (PVC)IBA
01/2021 - 11/2017
22- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acidIBA
01/2021 - 12/2019
2Prednisone (Sone)FDA LinkGeneric
10/2020 - 08/2017
2LigandsIBA
10/2020 - 10/2018
2GadoliniumIBA
01/2020 - 10/2016
289Zr-bevacizumabIBA
01/2018 - 05/2017
2RadiopharmaceuticalsIBA
08/2017 - 01/2016
2dipinacoline glutamateIBA
05/2017 - 01/2014
2ThyroglobulinFDA Link
05/2016 - 06/2014
2Immunoconjugates (Immunoconjugate)IBA
04/2016 - 01/2016
2Aurora Kinase AIBA
01/2016 - 01/2016
2Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2016 - 12/2006
2Cetuximab (Erbitux)FDA Link
01/2016 - 10/2015
2PK 11195 (PK11195)IBA
09/2015 - 04/2012
2cabazitaxelFDA Link
06/2015 - 02/2013
2Technetium (Technetium 99m)IBA
02/2013 - 09/2007
2CalciumIBA
04/2012 - 04/2012
1pembrolizumabIBA
03/2022
1durvalumabIBA
01/2022
1Sorafenib (BAY 43-9006)FDA Link
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2020
1Vincristine (Oncovin)FDA LinkGeneric
10/2020
1NivolumabIBA
10/2020
1BMS-986192IBA
10/2020
116-fluoroestradiolIBA
04/2020

Therapy/Procedure

30Therapeutics
01/2021 - 01/2002
19Radiotherapy
06/2022 - 09/2004
11Chemoradiotherapy
06/2022 - 07/2008
11Drug Therapy (Chemotherapy)
06/2015 - 10/2002
7Castration
07/2019 - 01/2016
5Neck Dissection (Radical Neck Dissection)
02/2017 - 10/2004
4Neoadjuvant Therapy
01/2011 - 09/2005
3General Anesthesia
02/2016 - 11/2007
3Laryngectomy
02/2016 - 11/2007
3Aftercare (After-Treatment)
11/2014 - 10/2010
3Thoracotomy
04/2006 - 04/2002
2Lymph Node Excision (Lymph Node Dissection)
01/2020 - 11/2002